Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Jul;89(1):131–135. doi: 10.1111/j.1365-2249.1992.tb06891.x

Effect of fatty acid anilides on immune responses of Swiss mice.

R Blasco 1, V Ruiz-Gutierrez 1
PMCID: PMC1554401  PMID: 1385764

Abstract

The possible relationship between fatty acid anilides and the toxic oil syndrome (TOS) which appeared in Spain in 1981 has been debated during recent years. These anilides have been detected as anomalous compound in toxic oils analysed. After treatment with one daily dose of 50 mg/kg of oleilanilide (88.86% pure) for 5 days, animals showed a tendency towards progressive loss of body weight and a significant increase in serum concentration of immunoglobulins. The percentage of suppressor T cells in spleen diminished significantly compared with the control group. Consequently, an increase in the helper T cells/suppressor T cells was also observed. The production of IgM and IgG in culture was significantly higher than in controls and no differences were seen in IgA synthesis. The functional studies of generation of specific IgM, IgA and IgG suppressor cells at variable doses of concanavalin A (Con A) showed paradoxical behaviour of suppressor T cells generated by low doses of Con A. A similar change occurred at higher doses of Con A. These results suggest that low-dose treatment with oleilanilides induces an alteration in the immune response in Swiss mice.

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blasco R., Moreno E., Sanz P., Repetto M. In vitro modifications of rat NTE and other esterases by chemicals which induce delayed neurotoxicity in vivo. Vet Hum Toxicol. 1990 Oct;32(5):435–439. [PubMed] [Google Scholar]
  2. Brandtzaeg P. Transport models for secretory IgA and secretory IgM. Clin Exp Immunol. 1981 May;44(2):221–232. [PMC free article] [PubMed] [Google Scholar]
  3. Egido J., Sancho J., Rivera F., Hernando L. The role of IgA and IgG immune complexes in IgA nephropathy. Nephron. 1984;36(1):52–59. doi: 10.1159/000183115. [DOI] [PubMed] [Google Scholar]
  4. Fournier E., Efthymiou M. L., Lecorsier A. Spanish adulterated oil matter. An important discovery by Spanish toxicologists: the toxicity of anilides of unsaturated fatty acids. Toxicol Eur Res. 1982 Mar;4(2):107–112. [PubMed] [Google Scholar]
  5. Kammüller M. E., Bloksma N., Seinen W. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds. J Toxicol Clin Toxicol. 1988;26(3-4):157–174. doi: 10.3109/15563658809000344. [DOI] [PubMed] [Google Scholar]
  6. Marquet A., Larraga V., Diez J. L., Amela C., Rodrigo J., Muñoz E., Pestaña A. Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome. Experientia. 1984 Sep 15;40(9):977–980. doi: 10.1007/BF01946468. [DOI] [PubMed] [Google Scholar]
  7. Miller K. B., Schwartz R. S. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med. 1979 Oct 11;301(15):803–809. doi: 10.1056/NEJM197910113011502. [DOI] [PubMed] [Google Scholar]
  8. Russell M. W., Brown T. A., Mestecky J. Role of serum IgA. Hepatobiliary transport of circulating antigen. J Exp Med. 1981 Apr 1;153(4):968–976. doi: 10.1084/jem.153.4.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sanz P., Carrasco M. J., Repetto M. Inhibition of Hill reaction produced by fatty acid anilides. Bull Environ Contam Toxicol. 1987 Apr;38(4):602–609. doi: 10.1007/BF01608592. [DOI] [PubMed] [Google Scholar]
  10. Sanz P., Moreno E., Blasco R., Repetto M. Study of delayed neurotoxicity caused by fatty acid anilides in hens. Vet Hum Toxicol. 1990 Oct;32(5):422–427. [PubMed] [Google Scholar]
  11. Sanz P., Rodriguez-Vicente M. C., Villar P., Repetto M. Inhibition of glucose-6-phosphatase and adenosine-triphosphatase activity in rats treated with toxic Spanish rapeseed oil or synthetic anilides. Vet Hum Toxicol. 1986 Oct;28(5):409–411. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES